(Q22306118)

21 April 2023

M. H. Stoler

2

Mark H

Stoler

1 reference

21 April 2023

A. Sharma

3

Abha

Sharma

1 reference

21 April 2023

G. Zhang

4

Guili

Zhang

1 reference

21 April 2023

C. Behrens

5

Catherine

Behrens

1 reference

21 April 2023

T. L. Wright

6

Teresa L

Wright

1 reference

American Journal of Clinical Pathology

21 April 2023

language of work or name

English

0 references

publication date

13 September 2011

0 references

published in

0 references

volume

136

0 references

issue

4

0 references

page(s)

578-586

0 references

cites work

Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

The 2001 Bethesda System: terminology for reporting results of cervical cytology

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Estimating prevalence when the true disease status is incompletely ascertained.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Risk assessment to guide the prevention of cervical cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPTUS5EXAS6DKZ

7 January 2021

Identifiers

DOI

10.1309/AJCPTUS5EXAS6DKZ

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017